Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AbCellera Biologics Inc (ABCL) vs Manulife Financial Corporation (MFC) Price & Performance

AbCellera Biologics IncTrade
Manulife Financial CorporationTrade

Price performance (Past 24H)

Key statistics

AbCellera Biologics Inc vs Manulife Financial Corporation — how do they compare? AbCellera Biologics Inc trades at $9.18 (market cap $2.99B), while Manulife Financial Corporation trades at $43.84 (market cap $72.68B). The key difference: Manulife Financial Corporation is far larger — about 24.3× AbCellera Biologics Inc's market cap, and Manulife Financial Corporation pays a 3.1% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.

ABCLMFC
Market Cap
$2.99B$72.68B
Sector
HealthFinancials
52-Week High
$9.76$44.77
52-Week Low
$2.78$30.06
Enterprise Value
$2.58B$67.84B
Dividend Yield
3.1%

Returns comparison

Trailing returns across standard periods

About AbCellera Biologics Inc

AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.

Read more on ABCL

About Manulife Financial Corporation

Manulife provides life insurance and wealth management products and services to individuals and group customers in Canada, the United States, and Asia. Manulife is one of Canada's Big Three Life Insurance companies (the other two are Sun Life and Great West Life). As of Dec. 31, 2021, Manulife reported assets under management or administration of about CAD $1.4 trillion.

Read more on MFC